Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact.

IF 3.4 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Juan Jose Garcia Sanchez, Katherine A Barraclough, Aleix Cases, Roberto Pecoits-Filho, Celine Germond-Duret, Carmine Zoccali, Nina Embleton, Antony Wright, Luke Hubbert, Lindsay Nicholson, Salvatore Barone, Nigel Budgen, Claudia Cabrera, Viknesh Selvarajah, Matthew J Eckelman
{"title":"Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact.","authors":"Juan Jose Garcia Sanchez, Katherine A Barraclough, Aleix Cases, Roberto Pecoits-Filho, Celine Germond-Duret, Carmine Zoccali, Nina Embleton, Antony Wright, Luke Hubbert, Lindsay Nicholson, Salvatore Barone, Nigel Budgen, Claudia Cabrera, Viknesh Selvarajah, Matthew J Eckelman","doi":"10.1007/s12325-024-03039-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>While the economic and clinical burden of chronic diseases are well documented, their environmental impact remains poorly understood. We developed a framework to estimate the environmental impact of a disease care pathway using chronic kidney disease (CKD) as an example.</p><p><strong>Methods: </strong>A life cycle assessment framework was developed for the CKD care pathway and validated by experts. Life cycle stages were characterised for resource utilisation based on a literature review and ecoinvent database inputs, in ten countries. The ReCiPe impact assessment method was used to calculate impacts across multiple environmental dimensions.</p><p><strong>Results: </strong>At CKD stage 5, kidney replacement therapies (KRT) have highest impact; emissions ranged between 3.5 and 43.9 kg carbon dioxide equivalents (CO<sub>2</sub>e) per session depending on dialysis modality, and 336-2022 kg CO<sub>2</sub>e for kidney transplant surgery, depending on donor type. Hospitalisations have a substantial environmental impact: a 1-day intensive care stay had highest impact (66.4-143.6 kg CO<sub>2</sub>e), followed by a 1-day hospital stay (28.8-63.9 kg CO<sub>2</sub>e) and an 8-h emergency room visit (14.4-27.5  kg CO<sub>2</sub>e). Patient transport to and from healthcare sites was a key driver of environmental impact for all life cycle stages, representing up to 99.5% of total CO<sub>2</sub>e emissions.</p><p><strong>Conclusion: </strong>Full care pathways should be analysed alongside specific healthcare processes. Application of this framework enables quantification of the environmental benefits of preventative medicine and effective management of chronic diseases. For CKD, early diagnosis, and proactive management to reduce the need for KRT and hospitalisations could improve patient outcomes and reduce environmental burden.</p>","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12325-024-03039-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: While the economic and clinical burden of chronic diseases are well documented, their environmental impact remains poorly understood. We developed a framework to estimate the environmental impact of a disease care pathway using chronic kidney disease (CKD) as an example.

Methods: A life cycle assessment framework was developed for the CKD care pathway and validated by experts. Life cycle stages were characterised for resource utilisation based on a literature review and ecoinvent database inputs, in ten countries. The ReCiPe impact assessment method was used to calculate impacts across multiple environmental dimensions.

Results: At CKD stage 5, kidney replacement therapies (KRT) have highest impact; emissions ranged between 3.5 and 43.9 kg carbon dioxide equivalents (CO2e) per session depending on dialysis modality, and 336-2022 kg CO2e for kidney transplant surgery, depending on donor type. Hospitalisations have a substantial environmental impact: a 1-day intensive care stay had highest impact (66.4-143.6 kg CO2e), followed by a 1-day hospital stay (28.8-63.9 kg CO2e) and an 8-h emergency room visit (14.4-27.5  kg CO2e). Patient transport to and from healthcare sites was a key driver of environmental impact for all life cycle stages, representing up to 99.5% of total CO2e emissions.

Conclusion: Full care pathways should be analysed alongside specific healthcare processes. Application of this framework enables quantification of the environmental benefits of preventative medicine and effective management of chronic diseases. For CKD, early diagnosis, and proactive management to reduce the need for KRT and hospitalisations could improve patient outcomes and reduce environmental burden.

将慢性肾脏病作为估算医疗相关环境影响的模型框架。
导言:虽然慢性病造成的经济和临床负担有据可查,但其对环境的影响却鲜为人知。我们以慢性肾脏病(CKD)为例,开发了一个估算疾病护理路径对环境影响的框架:方法:我们为慢性肾脏病护理路径开发了一个生命周期评估框架,并由专家进行了验证。在文献综述和 ecoinvent 数据库输入的基础上,对 10 个国家的生命周期阶段进行了资源利用特征描述。采用 ReCiPe 影响评估方法计算多个环境维度的影响:结果:在 CKD 第 5 阶段,肾脏替代疗法(KRT)的影响最大;根据透析方式的不同,每次透析的二氧化碳排放量在 3.5 至 43.9 千克二氧化碳当量(CO2e)之间;根据捐献者类型的不同,肾脏移植手术的二氧化碳排放量在 336 至 2022 千克二氧化碳当量之间。住院对环境的影响很大:1 天重症监护住院对环境的影响最大(66.4-143.6 千克二氧化碳当量),其次是 1 天住院(28.8-63.9 千克二氧化碳当量)和 8 小时急诊(14.4-27.5 千克二氧化碳当量)。在所有生命周期阶段,患者往返医疗机构的交通都是造成环境影响的主要因素,占二氧化碳排放总量的 99.5%:结论:在分析具体医疗流程的同时,还应分析完整的医疗路径。应用该框架可量化预防医学和慢性病有效管理对环境的益处。对于慢性肾脏病而言,早期诊断和积极管理以减少对 KRT 和住院的需求,可改善患者预后并减轻环境负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Therapy
Advances in Therapy 医学-药学
CiteScore
7.20
自引率
2.60%
发文量
353
审稿时长
6-12 weeks
期刊介绍: Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信